Risk factors for anal HPV infection and anal precancer in HIV-infected men who have sex with men

Journal of Infectious Diseases

Volumn 208, Issue 11, 2013, Pages 1768-1775

  Schwartz, Lauren M ^a   Castle, Philip E ^b   Follansbee, Stephen ^c   Borgonovo, Sylvia ^c   Fetterman, Barbara ^c   Tokugawa, Diane ^c   Lorey, Thomas S ^c   Sahasrabuddhe, Vikrant V ^a   Luhn, Patricia ^a   Gage, Julia C ^a   Darragh, Teresa M ^d   Wentzensen, Nicolas ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Global Cancer Initiative   (United States)

^c KAISER PERMANENTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anal cancer; Anal intraepithelial neoplasia (ain); Human immunodeficiency virus (hIV); Human papillomavirus (HPV); Men who have sex with men (MSM)

Indexed keywords

ADULT; ANUS CANCER; ARTICLE; CANCER GROWTH; CANCER RISK; CD4 LYMPHOCYTE COUNT; CHLAMYDIASIS; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; PAPILLOMAVIRUS INFECTION; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SMOKING; UNITED STATES; UTERINE CERVIX CANCER; WART VIRUS;

ANAL CANCER; ANAL INTRAEPITHELIAL NEOPLASIA (AIN); HUMAN IMMUNODEFICIENCY VIRUS (HIV); HUMAN PAPILLOMAVIRUS (HPV); MEN WHO HAVE SEX WITH MEN (MSM);

ADOLESCENT; ADULT; ANAL CANAL; ANUS NEOPLASMS; CALIFORNIA; CD4 LYMPHOCYTE COUNT; CHLAMYDIA INFECTIONS; CONFIDENCE INTERVALS; DEMOGRAPHY; HIV INFECTIONS; HIV SEROPOSITIVITY; HOMOSEXUALITY, MALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; RISK FACTORS; SEXUAL BEHAVIOR; SMOKING; YOUNG ADULT;

EID: 84888594539     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit374     Document Type: Article

References (39)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62:10-29.
2. Silverberg MJ, Lau B, Justice AC, et al. Risk of anal cancer in HIV infected and HIV-uninfected individuals in North America. Clin Infect Dis 2012; 54:1026-34.
3. De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta-analysis. Int J Cancer 2009; 124:1626-36.
4. Machalek DA, Poynten M, Jin F, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: A systematic review and meta-analysis. Lancet Oncol 2012; 13:487-500.
5. Palefsky JM, Rubin M. The epidemiology of anal human papillomavirus and related neoplasia. Obstet Gynecol Clin North Am 2009; 36:187-200.
6. Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 2008; 148:728-36.
7. Hessol NA, Pipkin S, Schwarcz S, Cress RD, Bacchetti P, Scheer S. The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. Am J Epidemiol 2007; 165:1143-53.
8. Shiels MS, Pfeiffer RM, Gail MH, et al. Cancer burden in the HIV infected population in the United States. J Natl Cancer Inst 2011; 103:753-62.
9. Wang SS, Zuna RE, Wentzensen N, et al. Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants. Cancer Epidemiol Biomarkers Prev 2009; 18:113-20.
10. Gadducci A, Barsotti C, Cosio S, Domenici L, Riccardo Genazzani A. Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: A review of the literature. Gynecol Endocrinol 2011; 27:597-604.
11. Gargano JW, Nisenbaum R, Lee DR, et al. Age-group differences in human papillomavirus types and cofactors for cervical intraepithelial neoplasia 3 among women referred to colposcopy. Cancer Epidemiol Biomarkers Prev 2012; 21:111-21.
12. Jong E, van Gorp EC, Mulder JW, Tol A, Smits PH. Effect of HIV viral load, CD4 cell count and antiretroviral therapy on human papillomavirus prevalence in urine samples of HIV-infected men. Int J STD AIDS 2009; 20:262-4.
13. Yu CT, Chao SC, Lee HC, et al. High prevalence of anal human papillomavirus infection and associated risky behaviors in men infected with human immunodeficiency virus in Taiwan. AIDS Behav 2013; 17:1211-8.
14. Palefsky JM, Holly EA, Ralston ML, Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis 1998; 177:361-7.
15. Guimaraes MD, Grinsztejn B, Melo VH, et al. Anal HPV prevalence and associated factors among HIV-seropositive men under antiretroviral treatment in Brazil. J Acquir Immune Defic Syndr 2011; 57(Suppl 3):S217-24.
16. Nyitray AG, Carvalho da Silva RJ, Baggio ML, et al. Six-month incidence, persistence, and factors associated with persistence of anal human papillomavirus in men: The HPV in men study. J Infect Dis 2011; 204:1711-22.
17. Phanuphak N, Teeratakulpisarn N, Pankam T, et al. Anal human papillomavirus infection among Thai men who have sex with men with and without HIV infection: prevalence, incidence, and persistence. J Acquir Immune Defic Syndr 2013, 63:472-9.
18. Linam JM, Chand RR, Broudy VC, et al. Evaluation of the impact of HIV serostatus, tobacco smoking and CD4 counts on epidermoid anal cancer survival. Int J STD AIDS 2012; 23:77-82.
19. Daling JR, Madeleine MM, Johnson LG, et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004; 101:270-80.
20. Castle PE, Follansbee S, Borgonovo S, et al. A comparison of human papillomavirus genotype-specific DNA and E6/E7 mRNA detection to identify anal precancer among HIV-infected men who have sex with men. Cancer Epidemiol Biomarkers Prev 2013; 22:42-9.
21. Wentzensen N, Follansbee S, Borgonovo S, et al. Human papillomavirus genotyping, human papillomavirus mRNA expression, and p16/Ki-67 cytology to detect anal cancer precursors in HIV-infected MSM. AIDS 2012; 26:2185-92.
22. Sahasrabuddhe VV, Castle PE, Follansbee S, et al. Human papillomavirus genotype attribution and estimation of preventable fraction of anal intraepithelial neoplasia cases among HIV-infected men who have sex with men. J Infect Dis 2013; 207:392-401.
23. Darragh TM, Tokugawa D, Castle PE, et al. Interrater agreement of anal cytology. Cancer Cytopathol 2013; 121:72-8.
24. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 2002; 287:2114-9.
25. Gage JC, Sadorra M, Lamere BJ, et al. Comparison of the cobas human papillomavirus (HPV) test with the hybrid capture 2 and linear array HPV DNA tests. J Clin Microbiol 2012; 50:61-5.
26. Palefsky JM. Human papillomavirus infection and anogenital neoplasia in human immunodeficiency virus-positive men and women. J Natl Cancer Inst Monogr 1998:15-20.
27. Chin-Hong PV, Vittinghoff E, Cranston RD, et al. Age-related prevalence of anal cancer precursors in homosexual men: The EXPLORE study. J Natl Cancer Inst 2005; 97:896-905.
28. D'Souza G, Wiley DJ, Li X, et al. Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 2008; 48:491-9.
29. Quinn R, Salvatierra J, Solari V, Calderon M, Ton TG, Zunt JR. Human papillomavirus infection in men who have sex with men in Lima, Peru. AIDS Res Hum Retroviruses 2012; 28:1734-8.
30. Rosa-Cunha I, Degennaro VA, Hartmann R, et al. Description of a pilot anal pap smear screening program among individuals attending a Veteran's Affairs HIV clinic. AIDS Patient Care STDS 2011; 25:213-9.
31. Samoff E, Koumans EH, Markowitz LE, et al. Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol 2005; 162:668-75.
32. de Pokomandy A, Rouleau D, Ghattas G, et al. HAART and progression to high-grade anal intraepithelial neoplasia in men who have sex with men and are infected with HIV. Clin Infect Dis 2011; 52:1174-81.
33. Mitra S, Crane L. Diagnosis, treatment, and prevention of anal cancer. Curr Infect Dis Rep 2012; 14:61-6.
34. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997; 102:3-8.
35. Mane A, Nirmalkar A, Risbud AR, Vermund SH, Mehendale SM, Sahasrabuddhe VV. HPV genotype distribution in cervical intraepithelial neoplasia among HIV-infected women in Pune, India. PLoS One 2012; 7:e38731.
36. De Vuyst H, Ndirangu G, Moodley M, et al. Prevalence of human papillomavirus in women with invasive cervical carcinoma by HIV status in Kenya and South Africa. Int J Cancer 2012; 131: 949-55.
37. Wentzensen N. Screening for anal cancer: endpoints needed. Lancet Oncol 2012; 13:438-40.
38. Darragh TM, Winkler B. Anal cancer and cervical cancer screening: key differences. Cancer Cytopathol 2011; 119:5-19.
39. Palefsky J, Berry JM, Jay N. Anal cancer screening. Lancet Oncol 2012; 13:e279-80.